Filtered By:
Specialty: Cardiology
Source: ESC Heart Failure
Condition: Cardiomyopathy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 26 results found since Jan 2013.
The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy
ConclusionsPatients with LVRR had a lower LV volume index, lower LVSV index, lower LGE extent, higher LVRI, and preserved myocardial deformation in the longitudinal direction at baseline. LVRI and rGLPS at baseline were independent determinants of LVRR.
Source: ESC Heart Failure - September 12, 2023 Category: Cardiology Authors: Ao Kan,
Qimin Fang,
Shuhao Li,
Wenying Liu,
Xinwei Tao,
Kaiyao Huang,
Mengyao Hu,
Zhaofeng Feng,
Lianggeng Gong Tags: Original Article Source Type: research
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes
ConclusionsThis study suggests that LVT resolution is an important predictor for favourable clinical outcomes. LVEF improvement failure interfered with LVT resolution and appeared to be a crucial factor for LVT recurrence. After LVT resolution, continuation of anticoagulation did not seem to impact LVT recurrence and the prognosis.
Source: ESC Heart Failure - April 4, 2023 Category: Cardiology Authors: Se ‐Eun Kim,
Chan Joo Lee,
Jaewon Oh,
Seok‐Min Kang Tags: Original Article Source Type: research
Characteristics and long ‐term survival of patients with left ventricular non‐compaction cardiomyopathy
ConclusionsOur study questions the criteria being used for the diagnosis of LVNC. Further evaluation of CMR variables and association of these findings with demographic variables and survival is mandatory.
Source: ESC Heart Failure - September 16, 2022 Category: Cardiology Authors: Emre Demir,
Selen Bayraktaro ğlu,
Akın Çinkooğlu,
Aytaç Candemir,
Yeşim B. Candemir,
Rıza O. Öztürk,
Ömer F. Dadaş,
Mehmet N. Orman,
Mehdi Zoghi,
Azem Akıllı,
Naim Ceylan,
Cemil Gürgün,
Sanem Nalbantgil Tags: Original Article Source Type: research
Atrial cardiomyopathy: from cell to bedside
AbstractAtrial cardiomyopathy refers to structural and electrical remodelling of the atria, which can lead to impaired mechanical function. While historical studies have implicated atrial fibrillation as the leading cause of cardioembolic stroke, atrial cardiomyopathy may be an important, underestimated contributor. To date, the relationship between atrial cardiomyopathy, atrial fibrillation, and cardioembolic stroke remains obscure. This review summarizes the pathogenesis of atrial cardiomyopathy, with a special focus on neurohormonal and inflammatory mechanisms, as well as the role of adipose tissue, especially epicardia...
Source: ESC Heart Failure - August 3, 2022 Category: Cardiology Authors: Mengmeng Li,
Yuye Ning,
Gary Tse,
Ardan M. Saguner,
Meng Wei,
John D. Day,
Guogang Luo,
Guoliang Li Tags: Review Source Type: research
Blood ‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis
ConclusionsSeveral blood-based biomarkers were identified as predictors of HCM outcomes. Additional studies are required to validate their prognostic utility within current risk stratification models.
Source: ESC Heart Failure - July 17, 2022 Category: Cardiology Authors: Mark Jansen,
Sila Alg ül,
Laurens P. Bosman,
Michelle Michels,
Jolanda Velden,
Rudolf A. Boer,
J. Peter Tintelen,
Folkert W. Asselbergs,
Annette F. Baas Tags: Original Article Source Type: research
Impact of SARS ‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ConclusionsOver one-fourth of HCM patients infected with SARS-Cov-2 required hospitalization, including 6% in an ICU setting. Age and cardiac features related to HCM, including baseline functional class, left ventricular outflow tract obstruction, and systolic impairment, conveyed increased risk of mortality.
Source: ESC Heart Failure - June 3, 2022 Category: Cardiology Authors: Juan R. Gimeno,
Iacopo Olivotto,
Ana Isabel Rodr íguez,
Carolyn Y. Ho,
Adrián Fernández,
Alejandro Quiroga,
Mari Angeles Espinosa,
Cristina Gómez‐González,
María Robledo,
Lucas Tojal‐Sierra,
Sharlene M. Day,
Anjali Owens,
Roberto Bar Tags: Original Article Source Type: research
Very long ‐term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years
ConclusionsIn our cohort of patients, HCM-related mortality was relatively favourable. However, approximately half of the patients suffered from HCM-related adverse events during the follow-up period of 20 years. It is important for HCM patients to be carefully followed up over the long-term because HCM is a lifelong disease.
Source: ESC Heart Failure - June 2, 2022 Category: Cardiology Authors: Kenta Sugiura,
Toru Kubo,
Yuri Ochi,
Kazuya Miyagawa,
Yuichi Baba,
Tatsuya Noguchi,
Takayoshi Hirota,
Naohito Yamasaki,
Yoshinori L. Doi,
Hiroaki Kitaoka Tags: Original Article Source Type: research
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience
ConclusionsHeart transplantation is a curative treatment for ARVC, but due to frequent ventricular arrhythmias and RV predominant pathology, patients require unique considerations in regard to timing of evaluation, haemodynamic support options, and wait listing qualification.
Source: ESC Heart Failure - December 25, 2021 Category: Cardiology Authors: Paul J. Scheel,
Katherine Giuliano,
Crystal Tichnell,
Cynthia James,
Brittney Murray,
Harikrishna Tandri,
Debra Carter,
Tracey Fehr,
Priya Umapathi,
Joban Vaishnav,
Sabra C. Lewsey,
Steven Hsu,
Hugh Calkins,
Kavita Sharma,
Chun Woo Choi,
Ni Tags: Original Article Source Type: research
Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta ‐analysis
ConclusionsThe annual mortality risk in chronic Chagas cardiomyopathy is substantial and primarily attributable to cardiovascular causes. This risk significantly increases in patients with low left ventricular ejection fraction and those classified as AHA stages C and C/D.
Source: ESC Heart Failure - November 1, 2021 Category: Cardiology Authors: Sindhu Chadalawada,
Anis Rassi,
Omar Samara,
Anthony Monzon,
Deepika Gudapati,
Lilian Vargas Barahona,
Peter Hyson,
Stefan Sillau,
Luisa Mestroni,
Matthew Taylor,
Maria Consola ção Vieira Moreira,
Kristen DeSanto,
Nelson I. Agudelo Higuita, Tags: Original Research Article Source Type: research
Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction
ConclusionsDespite a decreased right ventricular function with higher BNP values, patients with HCM-LVSD and DCM showed comparable outcomes post-LVAD implantation.
Source: ESC Heart Failure - October 28, 2021 Category: Cardiology Authors: Nobuichiro Yagi,
Osamu Seguchi,
Hiroki Mochizuki,
Kensuke Kuroda,
Seiko Nakajima,
Takuya Watanabe,
Masanobu Yanase,
Naoki Tadokoro,
Satsuki Fukushima,
Tomoyuki Fujita,
Norihide Fukushima Tags: Original Research Article Source Type: research
Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually
AbstractCardiomyopathy comprises a heterogeneous group of myocardial abnormalities, structural or functional in nature, in the absence of coronary artery disease and other abnormal loading conditions. These myocardial pathologies can result in premature death or disability from progressive heart failure, arrhythmia, stroke, or other embolic events. The European Cardiomyopathy Registry reports a high stroke risk in cardiomyopathy patients ranging from 2.1% to 4.5%, as well as high prevalence of atrial fibrillation ranging from 14.0% to 48.5%. There is a growing interest in evaluating the risk of thromboembolism depending on...
Source: ESC Heart Failure - September 9, 2021 Category: Cardiology Authors: Xiaogang Zhu,
Zhenhua Wang,
Markus W. Ferrari,
Katharina Ferrari ‐Kuehne,
Javed Bulter,
Xiuying Xu,
Quanzhong Zhou,
Yuhui Zhang,
Jian Zhang Tags: Review Source Type: research
Sympathetic activation in heart failure with reduced and mildly reduced ejection fraction: the role of aetiology
ConclusionsMuscle sympathetic nerve activity parameters indicated significant sympathetic activation in both HFmrEF and HFrEF patients as compared with healthy controls with no difference in relation to ischaemic versus non-ischaemic aetiology.
Source: ESC Heart Failure - September 7, 2021 Category: Cardiology Authors: R éka Urbancsek,
Zoltán Csanádi,
Ildikó Noémi Forgács,
Tímea Bianka Papp,
Judit Boczán,
Judit Barta,
Csaba Jenei,
László Nagy,
László Rudas Tags: Original Research Article Source Type: research
Clinical significance of new ‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
ConclusionsIn our HCM registry in an aged Japanese community, a significant proportion developed AF. The presence of AF, particularly new-onset AF, was associated with increased incidence of HCM-related events. AF may not be just a marker of disease stage but an important trigger of adverse events.
Source: ESC Heart Failure - September 2, 2021 Category: Cardiology Authors: Toru Kubo,
Yuichi Baba,
Yuri Ochi,
Takayoshi Hirota,
Naohito Yamasaki,
Kazuya Kawai,
Katsuhito Yamamoto,
Fumiaki Kondo,
Kanji Bando,
Eisuke Yamada,
Takashi Furuno,
Toshikazu Yabe,
Yoshinori L. Doi,
Hiroaki Kitaoka Tags: Original Research Article Source Type: research
Outcomes in patients with anthracycline ‐induced cardiomyopathy undergoing left ventricular assist devices implantation
ConclusionsAfter receiving a CF-LVAD, survival in patients with anthracycline-induced cardiomyopathy is similar to those with ICM or IDM. Further research into differential secondary endpoints-related disparities is warranted.
Source: ESC Heart Failure - May 13, 2021 Category: Cardiology Authors: Avirup Guha,
Cesar Caraballo,
Prantesh Jain,
P. Elliott Miller,
Jocelyn Owusu ‐Guha,
Katherine A.A. Clark,
Eric J. Velazquez,
Tariq Ahmad,
Lauren A. Baldassarre,
Daniel Addison,
Neal L. Weintraub,
Nihar R. Desai Tags: Original Research Article Source Type: research
A mid ‐ventricular variant of Takotsubo syndrome: was it triggered by insular cortex damage?
We report the case of a 79 ‐year‐old female diagnosed with a mid‐ventricular variant of TTS concomitant with right IC ischaemic stroke. After 12 h of hospitalization, she experienced a sudden collapse. Rapid cardiopulmonary resuscitation resulted in a return of spontaneous circulation. Subsequent left ventriculography revealed akinesis in the mid‐portion of the left ventricle with vigorous contraction of the basal and apex segment. Two weeks after admission, cardiac ultrasound showed improved left ventricular contraction. Right IC ischaemia in this patient might have been associated with a dysregulation of the CAN...
Source: ESC Heart Failure - May 3, 2021 Category: Cardiology Authors: Ayano Osawa,
Michiaki Nagai,
Keigo Dote,
Masaya Kato,
Noboru Oda,
Eiji Kunita,
Eisuke Kagawa,
Aya Yamane,
Hiroshi Kobatake,
Haruko Shiota,
Naoki Ishibashi,
Kazuki Takahashi,
Carola Y. F örster Tags: Case Report Source Type: research
